Epidemiology of acute hypoxaemic respiratory failure in Australian and New Zealand intensive care units during 2005–2022. A binational, registry-based study
Year: 2024
Type: article
Study design: Observational Study
Abstract: Acute hypoxaemic respiratory failure (AHRF) is a common reason for intensive care unit (ICU) admission. However, patient characteristics, outcomes, and trends over time are unclear. We describe the epidemiology and outcomes of patients with AHRF over time. In this binational, registry-based study from 2005 to 2022, we included all adults admitted to an Australian or New Zealand ICU with an arterial blood gas within the first 24 h of ICU stay. AHRF was defined as a partial pressure of oxygen/inspired oxygen ratio (PaO 2 /FiO 2 ) ≤ 300. The primary outcome was adjusted in-hospital mortality, categorised based on PaO 2 /FiO 2 (mild: 200–300, moderate: 100–200, and severe < 100, and non-linearly). We investigated how adjusted mortality evolved based on temporal trends (by year of admission), sex, age, admission diagnosis and the receipt of mechanical ventilation. Of 1,560,221 patients, 826,106 (52.9%) were admitted with or developed AHRF within the first 24 h of ICU stay. Of these 826,106 patients, 51.4% had mild, 39.3% had moderate, and 9.3% had severe AHRF. Compared to patients without AHRF (5.3%), patients with mild (8%), moderate (14.2%) and severe (29.9%) AHRF had higher in-hospital mortality rates. As PaO 2 /FiO 2 ratio decreased, adjusted in-hospital mortality progressively increased, particularly below an inflection point at a PaO 2 /FiO 2 ratio of 200. The adjusted in-hospital mortality for all patients decreased over time (13.3% in 2005 to 8.2% in 2022), and this trend was similar in patients with and without AHRF. The healthcare burden due to AHRF may be larger than expected, and mortality rates remain high in severe AHRF. Although mortality has decreased over time, this may reflect improvements in ICU care in general, rather than specifically in AHRF. More research is required to earlier identify AHRF and stratify these patients at risk of deterioration early, and to validate our findings.
Source: Intensive Care Medicine
Institutions: National University of Singapore, National University Hospital, National University Health System, Monash University, Nepean Hospital, Canberra Hospital, Peninsula Health, Monash Health, Dandenong Hospital, Gosford Hospital, University of Newcastle Australia, National University Heart Centre Singapore, The University of Queensland, UNSW Sydney, The George Institute for Global Health, Prince Charles Hospital, The Alfred Hospital, Australian and New Zealand Intensive Care Society, Bond University, Queensland University of Technology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,990
OpenAlex ID: W4402134595